You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華熙生物(688363.SH)業績快報:2021年度營收同比大幅增長87.93%、四大品牌均形成大單品矩陣
格隆匯 02-25 18:54

格隆匯2月25日丨華熙生物(688363.SH)發佈2021年度業績快報,實現營業收入49.48億元,同比增加87.93%;歸屬於母公司所有者的淨利潤7.82億元,同比增加21.13%;歸屬於母公司所有者的扣除非經常性損益的淨利潤6.63億元,同比增加16.74%;基本每股收益1.63元。

營業收入同比增長87.93%,主要原因系功能性護膚品銷售收入同比增長約146.57%,原料業務及醫療終端業務同比穩健增長。功能性護膚品業務方面,科技力對產品力的支撐深入推進,產品創新能力持續彰顯,報吿期內推出較多新產品;老用户復購貢獻增加,四大品牌均形成大單品矩陣;國民品牌建設頗具成效,品牌力得到明顯提升。原料業務同比增長約28.62%,增速比去年有較大提升,主要原因系醫藥級、化粧品級原料穩步增長的同時,食品級原料和其他原料獲得較大幅增長。

報吿期內,公司穩步推進“四輪驅動”業務佈局,原料業務和醫療終端業務穩步增長,功能性護膚品業務繼續保持高速增長,功能性食品業務獲得良好開局。

在收入保持較高速度增長的同時,公司高度重視長期持續增長所必須的基礎能力建設,包括進一步提升公司研發實力,繼續大幅增加研發投入;前瞻性佈局產能,為未來的銷售增長預留空間;持續提升功能性護膚品品牌力,打造國名品牌;系統培養人才,組織架構優化升級,打造工業 4.0 和建設大運營體系等。以上戰略投入較大使得公司 2021 年度營業收入增速高於同期營業利潤增速。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account